Nuzenio

Nccn Guidelines

Nccn Guidelines news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Natera seeks Japan’s PMDA approval for Signatera test in MIBC - Medical Device NetworkMedical Device Network · Thu, 06 Aug 2026 10:17:11 GMTNCCN Guidelines: Navigating ctDNA MRD Testing in Evolving MIBC Paradigms - CancerNetworkCancerNetwork · Wed, 05 Aug 2026 18:04:30 GMTMore Data Needed To Validate ctDNA Monitoring in Bladder Cancer Care - CancerNetworkCancerNetwork · Wed, 05 Aug 2026 13:10:09 GMTExplaining ctDNA Analysis Findings From SERENA-6 in Breast Cancer - OncLiveOncLive · Wed, 05 Aug 2026 02:10:38 GMTNavigating ctDNA-Guided Decision-Making in Muscle-Invasive Bladder Cancer - CancerNetworkCancerNetwork · Tue, 04 Aug 2026 22:09:15 GMTNCCN Guidelines Add Gedatolisib-Based Regimens for Pretreated PIK3CA Wild-Type Advanced Breast Cancer - OncLiveOncLive · Mon, 03 Aug 2026 15:13:18 GMTGedatolisib/Fulvestrant Earns NCCN Category 1 Listing for HR+/HER2- Breast Cancer - CancerNetworkCancerNetwork · Mon, 03 Aug 2026 12:08:52 GMTNewly FDA-Approved REVTORPYK™ (gedatolisib) Included in the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines for HR+/HER2- Locally Advanced or Metastatic Breast Cancer - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 12:30:00 GMT

Timeline

Thu, 06 Aug 2026 10:17:11 GMTNatera seeks Japan’s PMDA approval for Signatera test in MIBC - Medical Device Network
Wed, 05 Aug 2026 18:04:30 GMTNCCN Guidelines: Navigating ctDNA MRD Testing in Evolving MIBC Paradigms - CancerNetwork
Wed, 05 Aug 2026 13:10:09 GMTMore Data Needed To Validate ctDNA Monitoring in Bladder Cancer Care - CancerNetwork
Wed, 05 Aug 2026 02:10:38 GMTExplaining ctDNA Analysis Findings From SERENA-6 in Breast Cancer - OncLive
Tue, 04 Aug 2026 22:09:15 GMTNavigating ctDNA-Guided Decision-Making in Muscle-Invasive Bladder Cancer - CancerNetwork
Mon, 03 Aug 2026 15:13:18 GMTNCCN Guidelines Add Gedatolisib-Based Regimens for Pretreated PIK3CA Wild-Type Advanced Breast Cancer - OncLive

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Nccn Guidelines.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.